PerkinElmer Acquires Vanadis Diagnostics

PerkinElmer has acquired Vanadis Diagnostics, a Swedish company that is developing a novel solution for noninvasive prenatal testing based on digital analysis of cell-free DNA.

Terms were not disclosed.

The deal is anticipated to build upon PerkinElmer’s maternal fetal health offerings, which provide customers a portfolio of traditional serum screening solutions, the company says.

“The Vanadis platform will enable PerkinElmer to offer a simplified, cost-effective, high-throughput approach to NIPT to help facilitate wider access for pregnant women,” PerkinElmer says. — Jonathon Shacat